US Stock MarketDetailed Quotes

Spyre Therapeutics (SYRE)

Watchlist
  • 76.310
  • +1.270+1.69%
Close May 13 15:59 ET
  • 77.310
  • +1.000+1.31%
Pre 04:55 ET
6.63BMarket Cap-36.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Spyre Therapeutics (SYRE) Revenue Breakdown Overview

By Business/Source

Currency:USD
2023/FY
Stock NameRevenueRatio
Development of biopharmaceutical products for the treatment of patients with inflammatory bowel886K100.00%

By Country/Region

Currency:USD
2023/FY
Stock NameRevenueRatio
United States886K100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -